National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

Read this book online, free! Click here to proceed to linked table of contents

Breakthrough Business Models:

Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

Book Cover

Status: Available Now

Size: 150 pages, 6 x 9

Publication Year:2008


E-mail this page
Print List Price    
Order online and save 10%
PAPERBACK
ISBN-10: 0-309-12088-8
ISBN-13: 978-0-309-12088-3
$36.00   Add to Cart
PDF     About PDF

Authors:
Theresa Wizemann, Sally Robinson, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine
Authoring Organizations

Description:

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to ...
Read More


Paste into your Web page:

Preview
Free Resources
Read

Full Text
Jump to this book's table of contents to begin reading online for free.

Research Tools
Download Free

PDF Summary
Download the summary in PDF.

Rights & Permissions

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Description

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns.

On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Search This Book

»Find more like this book

SIGN UP FOR...

New Title Emails
Read about the newest releases and receive special offers.